Track Real Time Price

According to ChemAnalyst , The Guaifenesin Prices recorded a firm upward movement during the second quarter of 2026, with logistics and freight expenses emerging as important contributors to higher delivered costs across major consuming regions. Guaifenesin, an expectorant widely used in over-the-counter cough and cold formulations, is an established pharmaceutical ingredient with demand closely linked to pharmaceutical manufacturing, seasonal respiratory-care requirements, and the production of finished-dose medicines. During Q2 2026, the global guaifenesin market experienced noticeable cost pressure as freight rates, insurance expenses, container availability, and transit conditions affected international trade flows. While the underlying manufacturing economics remained relatively stable compared with logistics-related factors, higher transportation expenses translated into increased landed costs for buyers. In North America, the United States recorded a 7.719% quarter-over-quarter...

Introduction to Guaifenesin Market Dynamics Guaifenesin , a widely used active pharmaceutical ingredient (API), plays a crucial role in cough and cold formulations due to its expectorant properties. It is commonly utilized in over-the-counter (OTC) medications, making it highly sensitive to seasonal demand patterns, public health trends, and supply chain conditions. The  Guaifenesin prices  landscape in Q3 2025 reflected a mix of regional dynamics shaped by macroeconomic indicators, production costs, and shifting demand-supply balances. Across key regions including North America, Asia-Pacific (APAC), and Europe, price movements exhibited divergent trends. While North America experienced an upward trajectory, APAC and Europe witnessed declining prices due to weaker demand and easing production costs. This article provides a comprehensive analysis of  Guaifenesin prices , highlighting regional trends, cost drivers, and future outlook. Guaifenesin Prices in North America Str...